These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 16930912)

  • 61. Identification of the major metabolites of resveratrol in rat urine by HPLC-MS/MS.
    Wang D; Hang T; Wu C; Liu W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 829(1-2):97-106. PubMed ID: 16243591
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Discovery of Ecopladib, an indole inhibitor of cytosolic phospholipase A2alpha.
    Lee KL; Foley MA; Chen L; Behnke ML; Lovering FE; Kirincich SJ; Wang W; Shim J; Tam S; Shen MW; Khor S; Xu X; Goodwin DG; Ramarao MK; Nickerson-Nutter C; Donahue F; Ku MS; Clark JD; McKew JC
    J Med Chem; 2007 Mar; 50(6):1380-400. PubMed ID: 17305324
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 1-(3-biaryloxy-2-oxopropyl)indole-5-carboxylic acids and related compounds as dual inhibitors of human cytosolic phospholipase A2α and fatty acid amide hydrolase.
    Zahov S; Drews A; Hess M; Schulze Elfringhoff A; Lehr M
    ChemMedChem; 2011 Mar; 6(3):544-9. PubMed ID: 21259444
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In vitro metabolism of alisol A and its metabolites' identification using high-performance liquid chromatography-mass spectrometry.
    Yu Y; Liu Z; Ju P; Zhang Y; Zhang L; Bi K; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 941():31-7. PubMed ID: 24184833
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Synthesis and structural assignment of two major metabolites of the LTA4H inhibitor DG-051.
    Enache LA; Zhang J; Sullins DW; Kennedy I; Onua E; Zembower DE; Muellner FW; Singh J; Kiselyov AS
    Bioorg Med Chem Lett; 2009 Nov; 19(22):6275-9. PubMed ID: 19819140
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Production of a reactive metabolite of troglitazone by electrochemical oxidation performed in nonaqueous medium.
    Tahara K; Nishikawa T; Hattori Y; Iijima S; Kouno Y; Abe Y
    J Pharm Biomed Anal; 2009 Dec; 50(5):1030-6. PubMed ID: 19581066
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The metabolism and excretion of 2-methylaminoethoxycarbonyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2'-carboxylic acid (DDB-S) in rats and human.
    Yoo HH; Son J; Lee J; Kim NS; Shin M; Kang MJ; Kim DH
    Rapid Commun Mass Spectrom; 2006; 20(13):1981-8. PubMed ID: 16755608
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Structural elucidation of in vitro metabolites of emodin by liquid chromatography-tandem mass spectrometry.
    Song R; Xu F; Zhang Z; Liu Y; Dong H; Tian Y
    Biomed Chromatogr; 2008 Nov; 22(11):1230-6. PubMed ID: 18651591
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Metabolism studies of the anti-tumor agent maytansine and its analog ansamitocin P-3 using liquid chromatography/tandem mass spectrometry.
    Liu Z; Floss HG; Cassady JM; Chan KK
    J Mass Spectrom; 2005 Mar; 40(3):389-99. PubMed ID: 15674857
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Identification of 1-furan-2-yl-3-pyridin-2-yl-propenone, an antiinflammatory agent, and its metabolites in rat liver subcellular fractions.
    Lee SK; Jeon TW; Basnet A; Jeong HG; Lee ES; Jeong TC
    Arch Pharm Res; 2006 Nov; 29(11):984-9. PubMed ID: 17146967
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The metabolism of avermectin-H2B1a and -H2B1b by pig liver microsomes.
    Chiu SH; Sestokas E; Taub R; Smith JL; Arison B; Lu AY
    Drug Metab Dispos; 1984; 12(4):464-9. PubMed ID: 6148214
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Determination of arachidonic acid by on-line solid-phase extraction HPLC with UV detection for screening of cytosolic phospholipase A2α inhibitors.
    Hanekamp W; Lehr M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 900():79-84. PubMed ID: 22695324
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Metabolic profiling of a potential antifungal drug, 3-(4-bromophenyl)-5-acetoxymethyl-2,5-dihydrofuran-2-one, in mouse urine using high-performance liquid chromatography with UV photodiode-array and mass spectrometric detection.
    Nobilis M; Pour M; Senel P; Pavlík J; Kunes J; Voprsalová M; Kolárová L; Holcapek M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 853(1-2):10-9. PubMed ID: 17400036
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [In vitro comparison of thienorphine metabolism in liver microsomes of human, Beagle dog and rat].
    Deng JT; Zhuang XM; Li H
    Yao Xue Xue Bao; 2010 Jan; 45(1):98-103. PubMed ID: 21351457
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Quantitative LC/MS/MS method and pharmacokinetic studies of columbin, an anti-inflammation furanoditerpen isolated from Radix Tinosporae.
    Shi Q; Liang M; Zhang W; Zhang C; Liu R; Shen Y; Li H; Wang X; Wang X; Pan Q; Chen C
    Biomed Chromatogr; 2007 Jun; 21(6):642-8. PubMed ID: 17345572
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Microsomal metabolism of the 5-lipoxygenase inhibitors L-746,530 and L-739,010 to reactive intermediates that covalently bind to protein: the role of the 6,8-dioxabicyclo[3.2.1]octanyl moiety.
    Chauret N; Nicoll-Griffith D; Friesen R; Li C; Trimble L; Dubé D; Fortin R; Girard Y; Yergey J
    Drug Metab Dispos; 1995 Dec; 23(12):1325-34. PubMed ID: 8689939
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterization of new metabolites from in vivo biotransformation of norisoboldine by liquid chromatography/mass spectrometry and NMR spectroscopy.
    Chen JZ; Chou GX; Wang CH; Yang L; Bligh SW; Wang ZT
    J Pharm Biomed Anal; 2010 Sep; 52(5):687-93. PubMed ID: 20223612
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification and quantification of potential metabolites of Gd-based contrast agents by electrochemistry/separations/mass spectrometry.
    Telgmann L; Faber H; Jahn S; Melles D; Simon H; Sperling M; Karst U
    J Chromatogr A; 2012 Jun; 1240():147-55. PubMed ID: 22525874
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vitro biotransformations of the prostaglandin D2 (DP) antagonist MK-0524 and synthesis of metabolites.
    Nicoll-Griffith DA; Seto C; Aubin Y; Lévesque JF; Chauret N; Day S; Silva JM; Trimble LA; Truchon JF; Berthelette C; Lachance N; Wang Z; Sturino C; Braun M; Zamboni R; Young RN
    Bioorg Med Chem Lett; 2007 Jan; 17(2):301-4. PubMed ID: 17095220
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Normal phase and reverse phase HPLC-UV-MS analysis of process impurities for rapamycin analog ABT-578: application to active pharmaceutical ingredient process development.
    Chen Y; Brill GM; Benz NJ; Leanna MR; Dhaon MK; Rasmussen M; Zhou CC; Bruzek JA; Bellettini JR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):106-17. PubMed ID: 17826364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.